The National Institute of Health today said Google‘s (NSDQ:GOOG) Verily, formerly the company’s Life Sciences division, will advise Nashville, Tenn.’s Vanderbilt University to launch the 1st phase of the Precision Medicine Initiative Cohort, which was outlined by President Barack Obama last year.
The university is slated to test methods for engaging and enrolling volunteers through a web portal, aiming to enroll 79,000 volunteers by the end of the year. Participants will supply personal data to be used to improve health and treat diseases.
The initiative, launched last year by President Obama, is designed to track individual characteristics and data rather than “medicine based on one size fits all,” NIH director Dr. Francis Collins said.
The program will look at genetic factors as well as the role of environmental exposures and their impact on genetic predispositions.
More than 40 commitments to the project have emerged, according to the agency, with a wide array of nonprofits, universities, electronic health record vendors, tech companies, patient advocates and others.
The program is slated to include 1 million or more U.S. volunteers, spanning a diverse spectrum of age, economic background and racial groups. The NIH is working with the Health Resources and Services Administration to partner with community health enters to bring under-served individuals, families and communities into the program.
The NIH said it is also working to standardize applications to allow individuals to contribute data and has established an institutional review board to monitor the project.
Material from Reuters was used in this article.